A Study to Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infection
A Study to Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infection
Recruiting · NCT06801223 · Registry updated 2026-10-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infection | Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC) | Recruiting | Phase 1 | 2026-10-06 | NCT06801223 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Entasis Therapeutics | 1 |
| Innoviva Specialty Therapeutics | 6 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| ECU Brody School of Medicine | Greenville | United States | 1 |
| Rady Children's Hospital | San Diego | United States | 52 |
| UCLA Medical Center | Los Angeles | United States | 42 |
| University of Texas Medical Branch at Galveston | Galveston | United States | 1 |